Pharmacogenetics of CYP2C subfamily in a Japanese population.
Division of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
I
I
Ieiri
S
S
Higuchi
D001189:Aryl Hydrocarbon Hydroxylases; D065731:Cytochrome P-450 CYP2C19; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D005838:Genotype; D005885:Gingival Hyperplasia / Q000139:chemically induced; D006801:Humans; D006900:Hydroxylation; D007564:Japan; D006899:Mixed Function Oxygenases / Q000235:genetics*; D009154:Mutation; D010672:Phenytoin / Q000009:adverse effects / Q000378:metabolism*; D013237:Stereoisomerism; D039181:Steroid 16-alpha-Hydroxylase; D013250:Steroid Hydroxylases / Q000235:genetics*
D010672:Phenytoin; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D013250:Steroid Hydroxylases; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D039181:Steroid 16-alpha-Hydroxylase